Related Experiment Videos
[Clinical studies on SY5555 in pediatrics]
1Department of Pediatrics, Takamatsu Red Cross Hospital.
Insights
This study found SY5555 effective for treating bacterial infections in children. The antibiotic showed good to excellent clinical responses in all patients, eradicating most causative organisms.
Area of Science:
- Pediatric infectious diseases
- Bacteriology
- Clinical pharmacology
Background:
- Acute bacterial infections pose a significant health challenge in pediatric populations.
- Effective antibiotic therapy is crucial for managing pediatric bacterial infections and preventing complications.
Observation:
- SY5555, administered orally in dry syrup or tablet form, was given to 21 children with various acute bacterial infections.
- Infections included pharyngitis, tonsillitis, bronchitis, gastroenteritis, scarlet fever, lymphadenitis, and urinary tract infections.
Findings:
- All 21 pediatric patients achieved good to excellent clinical responses.
- Of 11 identified causative bacterial strains, 8 were eradicated, and 3 showed decreased counts.
- Minor adverse events included loose stools in 3 cases and eosinophilia in 1 case.
Implications:
- SY5555 demonstrates significant efficacy and tolerability as an antibiotic treatment for pediatric bacterial infections.
- These findings support the use of SY5555 in clinical practice for treating a range of bacterial infections in children.
- Further research could explore SY5555's efficacy against a broader spectrum of pediatric bacterial pathogens.
Abstract:
SY5555 in dry syrup (powder which is dissolved before use) or tablet form was given orally to 21 children with acute bacterial infections including 4 with acute pharyngitis, 5 with acute tonsillitis, 7 with acute bronchitis, 2 with acute gastroenteritis, 1 each with scarlet fever, acute lymphadenitis and urinary tract infection. Good to excellent clinical responses were obtained in all of the 21 patients and 8 of 11 strains found as causative organisms in these cases were eradicated and 3 strains were decreased. Loose stools were observed in 3 cases and eosinophilia was observed in 1 case. From the above clinical results, it appears that SY5555 is a useful antibiotic for the treatment of pediatric patients with various bacterial infections.